4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-021333
Options or other derivatives
- Chief Financial Officer acquired 350,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Swirsky Douglas J · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-27 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +350,000 | 350,000 | D |
Loading xslF345X04/doc4.xml…